When Onward was first diagnosed with chronic myeloid leukemia (CML), he spent many sleepless nights thinking about his future. Now, 11 years later, he advocates and provides support for other people going through the same thing.
“I am now living a normal life and enjoying my cycling, and gardening, and forgetting about CML, I only remember that I am a patient when it’s time to take my medication,” he said. “I now have hope, and I am able to instill hope to newly diagnosed patients.”
Onward is a 45-year-old farmer living in Zimbabwe with his wife, Tabeth, and their four children. In 2014, he started feeling weak and losing weight, and noticed he couldn’t cycle as far.
Onward said it took a while to be diagnosed then because the blood samples had to be taken to South Africa. He also had to sell his only car and furniture to afford the tests. Finally, a doctor confirmed that he had CML.
“My wife was so young at that stage, and I was just jealous and scared of losing her to someone else or not being able to grow old with her,” he said. “It wasn’t easy to accept.”
The doctor said medication was expensive, so he recommended our program. The Max Foundation and its partners provide access to treatment free of charge. After treatment, Onward started feeling better. He said every time he went for a checkup, there was good news.
In 2015, after encouragement from a Max team member, Onward became one of four founding members of the CML Zimbabwe Trust. They provide support, comfort, and education for patients. Currently, they’re letting people know about the transportation grants from Max to motivate them to seek treatment.
“I would like to thank the Max Foundation for the donation of the medication, which saves hundreds of patients in my country,” Onward said.
In 2022, Onward and Tabeth welcomed their fourth child, a son. Although he lost sleep over his diagnosis, Onward said he’s now proud to share his story and pass hope along to others.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Maximize Life Campaign: A Variety of Events but a Shared Message in Latin America
In Latin America, the Maximize Life Campaign has become something like a tradition – a time when each patient organization creates an event or activity of their choice and powers it up for a campaign that takes on a life of its own!
13 patient groups from 11 Latin American countries joined this year’s movement, bringing together patients and caregivers with the purpose of telling the community that cancer is an issue, that ignoring it is not going to make it go away, and that the best approach is to learn about it in order to know what to do about it. From governments to the general public, everybody can get involved in figuring out how to treat cancer patients as members of society and not as a burden.
Coming Together on World CML Day 2020
September 22 is World CML Day! Our Region Head Mei Ching Ong caught up with our partner physician in Armenia to talk about the importance of this day and bridging access to treatment and care for CML patients worldwide.
The Max Foundation & Friends of Max Bolster Long-standing Partnership with MOU Signing
The Max Foundation (Max) and Friends of Max (FOM) proudly announce the formalization of their long standing collaboration supporting people living with chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) in India. The two organizations signed a landmark Memorandum of Understanding (MOU) at the recent Friends of Max 2015 Leadership Summit attended by Max CEO, Pat Garcia-Gonzalez in Hyderabad on April 19th.
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.